SETi and Psoria-Shield, Inc. Enter Into Agreement to Commercialize Psoria-Light System and Expand Adoption for UVB Phototherapy

COLUMBIA, SC--(Marketwired - Dec 4, 2015) - Sensor Electronic Technology, Inc. (SETi), a world leader in UVB and UVC LEDs, has signed a long term agreement with Psoria-Shield, Inc. (PSI), a wholly-owned subsidiary of Wellness Center USA, Inc. (OTCQB: WCUI), to further develop the UV LED light source used exclusively in the Psoria-Light® (PL 1000) system manufactured and sold by PSI. The development is fundamentally based on increasing performance and reducing unit cost.

SETi plans to integrate its new high performance (308 nm) LED manufacturing process that emits up to 2mW of UVB power at 20mA drive current in a new high power light source delivering over 400mW of optical power. This performance and associated price/performance improvements make SETi LEDs a compelling solution for UVB dermatology treatments.

PSI is an advanced phototherapy company that has developed, manufactures, and distributes the Psoria-Light phototherapy system. The PL 1000 uses targeted high dosage UV LEDs with both cost and safety benefits to that of a conventional excimer laser. The result is an FDA cleared, highly effective system that is simple to use and requires no special laser room, no laser certification or special operator qualifications.

"A major advantage of our LED based technology is its solid state reliability and reduced maintenance coupled with it being a class 2 product, which does not require a physician to clinically provide the treatment. It can be delivered by office staff and be in compliance with existing billing codes. This allows offices and doctors to be more efficient," stated John Yorke, Managing Director of Psoria Development Corp (PDC). "We believe the treatment and use of UVB LEDs will become the industry standard. The PL 1000 is highly portable and can be moved from room to room, with no special power requirements," Yorke added. 

Emmanuel Lakios, President and CEO of SETi, added "Similar improvements have been made to power, lifetime and price/performance to our other 230nm to 340nm LED wavelengths. Of particular market demand is our germicidal 275nm LEDs." 

SETi now believes that along with the recent in-house increase in wafer capacity, the recent acquisition of Nitek, Inc. and its strategic relationship with UVA LED leader Seoul VioSys, its LEDs are the most cost effective, highest performing products on the market and will experience high adoption rates in 2016.

About SETi:
Sensor Electronic Technology, Inc. (SETi) is the world's leading manufacturer of deep UV LEDs with emission wavelengths from 230nm to 340nm, used in healthcare, life science, environmental, military and disinfection applications. SETi is the only company that covers the entire UV spectrum of LEDs from 230nm to 405nm and is the exclusive US distributor of Seoul VioSys for LEDs ranging from 340nm to 405nm.

About Wellness Center USA, Inc.
Wellness Center USA, Inc. (www.wellnesscenterusa.com) is a hybrid healthcare company that combines best in class technologies, software, devices, providers, protocols, goods, and services. It was created to address important healthcare and wellness needs via breakthrough solutions, all centered around the "well-being of the body and mind." Wellness Center USA, Inc. is the parent company of three businesses reporting consolidated: Stealth Mark, National Pain Centers, and Psoria-Shield.

Safe Harbor Statement:
Certain statements and projections contained in this presentation that are not statements or financial results of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements and projections include statements regarding any proposed exchange transactions, the anticipated closing date of such transactions and future results following a closing of the transactions. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "pending", "estimate," and "intend" or future or conditional verbs such as "will," "would," "should," "could," or "may." While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transactions and plans which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transactions, difficulties in integrating operations following the transactions, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.